EUVIMEDEUVIMED entdecken
Crossref

Peptide‐Triazolobenzodiazepine Hybrids: A Catalyst‐Free on‐Resin Strategy to Build Complex Therapeutic Motifs Into Peptides

Sandip Sushila Mohan Kamble, Supriya Mahadev Bodake, Udaya Kiran Marelli iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202500836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Sandip Sushila Mohan Kamble und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India. Hauptthemen laut MEDLINE: Peptides, Triazoles, Benzodiazepines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: National Chemical Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The merger of peptide and heterocyclic chemistry presents significant opportunities for enhancing the structural and functional diversity of therapeutic agents. In this study, we introduce a streamlined on‐resin method to modify peptides at the N ‐terminus amines and the side chain amines of Lys/Orn amino acids by incorporating the biologically active triazolobenzodiazepine scaffold. In the presented solid‐phase peptide synthesis (SPPS), the triazolobenzodiazepine core is formed on‐resin through a combination of N ‐alkylation, amide bond formation, and an alkyne‐azide 1,3‐dipolar cycloaddition, of which the latter two happen as a single‐step one‐pot reaction‐ proceeding under mild conditions without metal catalysts. This protocol tolerates a wide variety of amino acids and functional groups, providing a versatile method for synthesizing peptide‐triazolobenzodiazepine hybrids. Using orthogonal protection group strategies, we further demonstrate the method's adaptability for two site modifications in peptides involving both the N ‐terminus and Lys side chain amines. These modifications enhance the scope of “peptide medicinal chemistry” by creating multifunctional peptides with potential therapeutic applications. The method's compatibility with SPPS, room temperature conditions, and elimination of metal catalysis make it an efficient and powerful tool for peptide modification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesTriazolesBenzodiazepinesCatalysisSolid-Phase Synthesis TechniquesAminesCycloaddition ReactionAlkylationAmino AcidsAlkynes

Stichwörter der Autor:innen

hybrid peptidespeptide chemistrypeptide modificationspps compatibilitytriazolobenzodiazepines

Substanzen

PeptidesTriazolesAminesBenzodiazepinesAmino AcidsAlkynes

Autor:innen und Institutionen

  • Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India.
  • Central NMR Facility, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India.
  • CSIR-HRDC Campus, Academy of Scientific and Innovative Research (AcSIR), Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh, 201002, India.

ORCID-Profile: Udaya Kiran Marelli

Förderung

  • National Chemical Laboratory

Zitieren

APA

Kamble, S. S. M., Bodake, S. M., & Marelli, U. K. (2025). Peptide‐Triazolobenzodiazepine Hybrids: A Catalyst‐Free on‐Resin Strategy to Build Complex Therapeutic Motifs Into Peptides. Chemistry – A European Journal. https://doi.org/10.1002/chem.202500836

Vancouver

Kamble SSM, Bodake SM, Marelli UK. Peptide‐Triazolobenzodiazepine Hybrids: A Catalyst‐Free on‐Resin Strategy to Build Complex Therapeutic Motifs Into Peptides. Chemistry – A European Journal. 2025. doi:10.1002/chem.202500836

BibTeX
@article{Kamble2025,
  author = {Kamble, Sandip Sushila Mohan and Bodake, Supriya Mahadev and Marelli, Udaya Kiran},
  title = {Peptide‐Triazolobenzodiazepine Hybrids: A Catalyst‐Free on‐Resin Strategy to Build Complex Therapeutic Motifs Into Peptides},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202500836}
}
Kostenlos starten →